Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares (MOSAR-ICU)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
MJM Bonten, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00976638
First received: September 11, 2009
Last updated: August 3, 2012
Last verified: August 2012